Insider Transactions in Q1 2022 at Rain Therapeutics Inc. (RAIN)
Insider Transaction List (Q1 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 31
2022
|
Robert Doebele Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+0.42%
|
$6,000
$3.95 P/Share
|
Mar 11
2022
|
Avanish Vellanki Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,468
+0.51%
|
$57,872
$4.0 P/Share
|
Jan 07
2022
|
Bvf Partners L P Director |
BUY
Open market or private purchase
|
Direct |
496,385
+11.47%
|
$5,956,620
$12.0 P/Share
|
Jan 06
2022
|
Bvf Partners L P Director |
BUY
Open market or private purchase
|
Direct |
61,343
+5.1%
|
$736,116
$12.0 P/Share
|